A team of scientists from Western University in Canada has potentially discovered a promising avenue for treating amyotrophic lateral sclerosis (ALS), the devastating neurological condition commonly referred to as Lou Gehrig’s disease.
Their study suggests that two proteins might hold the key to preserving the nerve cells ravaged by the condition.
